In addition, recent studies have revealed that TTK functions as an oncogene in a variety of cancers, such as glioblastoma, breast, liver, prostate, lung, bladder, gastric, colon and pancreatic cancer [11–22], and knocking down TTK expression inhibits tumor growth. This evidence concerns the gene TTK and familial pancreatic carcinoma.